NCT00318734

Brief Summary

Cardiovascular disease (CVD) affects millions of people in the United States; each year, more people die from CVD than from any other disease. There are many dietary and lifestyle factors that may increase the risk of developing CVD. Preliminary research has shown that the presence of certain trace elements may be associated with the development of CVD. This study will examine toenail clippings and laboratory data to evaluate the link between trace elements and CVD risk factors in young adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,362

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 27, 2006

Completed
4 days until next milestone

Study Start

First participant enrolled

May 1, 2006

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
Last Updated

April 19, 2016

Status Verified

December 1, 2011

Enrollment Period

4.9 years

First QC Date

April 25, 2006

Last Update Submit

April 15, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • CVD risk factors

    1987-2010

Eligibility Criteria

Age20 Years - 32 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participating in the CARDIA study.

You may qualify if:

  • Enrolled in the CARDIA study; this current study will be using existing CARDIA study data and will not be recruiting any new participants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599-7461, United States

Location

MeSH Terms

Conditions

Cardiovascular DiseasesMetabolic SyndromeHypertensionInflammationAtherosclerosis

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesVascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsArteriosclerosisArterial Occlusive Diseases

Study Officials

  • Ka He, MD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2006

First Posted

April 27, 2006

Study Start

May 1, 2006

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

April 19, 2016

Record last verified: 2011-12

Locations